Jenscare Innovation

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Jenscare Innovation sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials none currently recruiting upper half by trial count

Jenscare Innovation: 1 sponsored US clinical trial, none currently recruiting.

Jenscare Innovation sponsors 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most-studied condition in this pipeline is Tricuspid Regurgitation (TR), with 1 trials.

Mid-pack sponsor footprint

Jenscare Innovation is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

Indexed trials (enrollment closed)

1 total, page 1 of 1

ACTIVE NOT RECRUITING NA

TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (TRINITY-US)

NCT06568003

Therapeutic Areas

Tricuspid Regurgitation (TR) 1

How the Jenscare Innovation archive is shaped

1 indexed studies, none listed as recruiting (0% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Tricuspid Regurgitation (TR) (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Jenscare Innovation: archived-pipeline peers nationwide

Peers matched on 1 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Jenscare Innovation sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60% Total trials Recruiting share Jenscare Innovation1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health10xBio22nd Century Group23andMe3-C Institute for Social Development
Jenscare Innovation sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Jenscare Innovation sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Jenscare Innovation page

1 registered trials is a research-attention snapshot, not an endorsement of Jenscare Innovation or any single study.

  • None of Jenscare Innovation's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Tricuspid Regurgitation (TR) is the condition Jenscare Innovation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Tricuspid Regurgitation (TR) trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Jenscare Innovation pipeline card: 1 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.